|
|
|
|
|
|
Soleno Therapeutics Inc (SLNO)
|
|
0.58 -0.04 (-6.45%)
|
9/20/2017 3:59pm
|
|
Open:
|
0.60
|
Pre. Close:
|
0.62
|
|
High:
|
0.62
|
Low:
|
0.55
|
|
Volume:
|
337,309
|
Market Cap:
|
27.79M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
-
|
-
|
|
Low:
|
-
|
-
|
|
Close:
|
-
|
-
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-20 4:42:46 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 0.86 One year: 1.01
|
|
Support:
|
Support1: 0.46 Support2: 0.29
|
|
Resistance:
|
Resistance1:
0.74 Resistance2: 0.86
|
|
Pivot:
|
0.58
|
|
Moving Averages:
|
MA(5): 0.62 MA(20): 0.56 
MA(100): 0.57 MA(250):
|
|
MACD:
|
MACD(12,26):
0.03 Signal(12,26,9): 0.03
|
|
%K %D:
|
%K(14,3): 65.74 %D(3): 70.31
|
|
RSI:
|
RSI(14): 53.32
|
|
52-Week:
|
High: 1.32
Low: 0.29 Change(%): -42.0
|
|
Average Vol(K):
|
3-Month: 16319
10-Days 15052
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.SLNO has closed above bottom band by 48.0%. Bollinger Bands are 14.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Tue, 05 Sep 2017 20:48:45 GMT
Soleno Therapeutics Announces CFO Transition
Mon, 24 Jul 2017 20:03:45 GMT
Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare, Inc.
Wed, 05 Jul 2017 12:00:00 GMT
Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in ...
Fri, 11 Aug 2017 20:03:45 GMT
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2017 ...
Wed, 13 Sep 2017 12:00:00 GMT
Soleno Therapeutics Announces Issuance of New US Patent for DCCR in Treatment ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
